rs752281590
Variant summary
Our verdict is Pathogenic. Variant got 25 ACMG points: 25P and 0B. PS1_Very_StrongPM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001378452.1(ITPR1):c.7660G>A(p.Gly2554Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2554W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001378452.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 25 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITPR1 | NM_001378452.1 | c.7660G>A | p.Gly2554Arg | missense_variant | 58/62 | ENST00000649015.2 | |
LOC124906209 | XR_007095795.1 | n.725-90C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITPR1 | ENST00000649015.2 | c.7660G>A | p.Gly2554Arg | missense_variant | 58/62 | NM_001378452.1 | |||
ENST00000693140.1 | n.581+11225C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249244Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135212
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461358Hom.: 0 Cov.: 38 AF XY: 0.00000138 AC XY: 1AN XY: 726952
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Gillespie syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | May 09, 2018 | PS3,PM6,PP2,PP3 - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 19, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27108798, 28191889, 31692161, 28659154, 28135719, 28628100, 32499604, 25533962) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2019 | - - |
Anterior segment dysgenesis Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Eye Genetics Research Group, Children's Medical Research Institute | Mar 31, 2020 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2016 | - - |
Spinocerebellar ataxia type 29 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at